Premier to join industry leaders at BDA London forum
HAMILTON, Bermuda, Nov. 23, 2017 (GLOBE NEWSWIRE) -- Premier David Burt will join more than two-dozen Bermuda executives in a multi-industry forum being held in London next week to showcase the breadth of expertise and advantages offered by the island's global business market.
A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/78c5ac53-07f7-4dd8-83e0-753ea5b4c80b
Organised by the Bermuda Business Development Agency (BDA), the one-day event Tuesday, November 28 at ME London has attracted over 200 registrants. It will feature top regulatory and industry leaders in moderated discussion panels covering re/insurance, captive insurance, insurance-linked securities, asset management, family offices, and trust and private-client business. A networking reception will wrap the event in the evening.
"The government supports the Bermuda Business Development Agency in this awareness-raising event that offers such great prospects for business executives to engage with our market's regulatory and industry leaders," said the Premier. "Bermuda is an excellent place to do business, with a respected record on transparency. That is our message as we seek to grow our economy and build careers for the Bermudian people."
Premier Burt will officially open the forum that will see morning panels debate risk-industry topics-from insurance trends and the outlook for 2018 to why Bermuda remains "the World's Risk Capital." Afternoon sessions will focus on the rapidly-growing convergence of re/insurance and asset management, then move to examine high-net-worth services, family governance and charitable trust structuring.
"This forum is an educational opportunity that demonstrates the strength of Bermuda as a centre of excellence across industry sectors," said BDA CEO Ross Webber, who will moderate the opening panel on Brexit and Solvency II. "The support we have received from our industry partners is impressive, and we're confident the event will help promote and differentiate Bermuda well in the key London market."
The day's line-up features 25 Bermuda executives, including Bermuda Monetary Authority CEO Jeremy Cox; Bermuda Stock Exchange CEO Greg Wojciechowski; Association of Bermuda Insurers & Reinsurers President Brad Kading; Grainne Richmond, President of the Bermuda Insurance Management Association (BIMA); and Keith Robinson, Chairman of the Society of Trust & Estate Practitioners (STEP) Bermuda. Deputy Chair of Lloyd's and Hiscox Chair Robert Childs is the event's keynote speaker.
Other Bermuda-based executive participants include Mark Allitt of KPMG Bermuda; Sarah Demerling of Estera; BDA former chair and Hiscox Director Caroline Foulger; David Gibbons of PwC Bermuda; Ed Granski for Meritus Trust; Randall Krebs of Harbour International Trust Company; BDA Board member Jessel Mendes, of EY Bermuda; Michael Neff of Butterfield Bank; Michael Parrish of Marsh Bermuda; Peter Pearman of Conyers Dill & Pearman; Brian Quinn of Granite Management; Fozeia Rana-Fahy of MJM; Aon CEO Joe Rego; Andrew Smith of Qatar Re; Ariane West of Taylors in association with Walkers; Arthur Wightman of PwC Bermuda; Kim Willey of ASW Law; and Akilah Wilson of the BMA.
Overseas presenters include Richard Hay of Stikeman Elliott, London; Siân Hill of KPMG UK; and Samantha Morgan of RMW Law.
"The timing of our event, following the recent Paradise Papers coverage and leading up to European Union code-of-conduct decisions next month, provides a great opportunity for Bermuda to tell our story," noted Webber. "Our top-tier regulation, our market's substantive global companies, our robust legislation, our respected record on international compliance, cooperation and tax transparency-all these advantages set Bermuda apart. Highlighting those facts through our world-class industry experts can only have a positive impact."
The following day, the ILS Bermuda group is hosting a complementary morning session at the same venue focused solely on insurance-linked securities. "Beyond Convergence" will provide a more detailed look at Bermuda's success in attracting capital, expertise and clients to the ILS sphere, as well as the rapid evolution of alternative reinsurance and the management of risk capital. Two sessions, moderated by ILS Bermuda Chair Greg Wojciechowski, will feature some of the same industry experts, including the BMA's Cox, ABIR's Kading, and BDA's Webber.
The BDA encourages direct investment and helps companies start up, re-locate or expand their operations in our premier jurisdiction. An independent, public-private partnership, we connect you to industry professionals, regulatory officials, and key contacts in the Bermuda government to assist domicile decisions. Our goal? To make doing business in Bermuda smooth and beneficial.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Bermuda Business Development Agency (BDA) via Globenewswire
Följ NASDAQ OMX
Abonnera på våra pressmeddelanden.
Senaste pressmeddelandena från NASDAQ OMX
Nitinat Provides Update on the Carscallen Gold Property19.3.2018 21:30 | Pressmeddelande
TORONTO, March 19, 2018 (GLOBE NEWSWIRE) -- Further to its press release dated March 12, 2018 whereby Nitinat Minerals Corp. (the "Corporation") (TSX-V:NZZ) (Frankfurt:04U1) announced its option to acquire four (4) additional claims (collectively, the "Claims") abutting the western boundaries of the Corporation's current mining claims in Carscallen Township, Ontario (the "Carscallen Gold Property"), the Corporation is pleased to provide additional information pertaining to the Claims. The Corporation intends to implement an exploration program for the Claims to fully explore the potential of the Claims. The "preliminary technical appraisal" provided herein, along with the geophysics that the Corporation intends to undertake, will identify potential drill targets. The property encompassing the Claims is of particular interest in that surface exploration to date on the Claims has shown the existence of historic surface mining and sampling. The Corporation is currently assessing the most
New Elemica Trace Solution Delivers Shipment Risk Analysis for Digital Transformation19.3.2018 13:09 | Pressmeddelande
Real-Time Information Matched with GPS Locations Provides Accurate Delivery Information WAYNE, Pa., March 19, 2018 (GLOBE NEWSWIRE) -- Elemica, the leading Digital Supply Network for process manufacturing industries, introduces Elemica Trace, a solution that provides real-time shipment and risk visibility to customer service, transport planners, and supply chain managers, allowing them to monitor and proactively manage the movement of products to customers and inbound to manufacturing centers. "Shipment disruptions occur and teams can spend hours manually tracking down what is happening. What's worse, sometimes your customer complaint is the first indication you have of a late shipment," said Rich Katz, CTO of Elemica. "Trace eliminates the time and stress of tracking shipments and enables your teams to increase the positive interactions with your customers." Elemica Trace uses shipment data, carrier signals, a geo-location interface, and predictive algorithms to identify shipments in
Resverlogix Exceeds Full Enrollment for the Pivotal Phase 3 BETonMACE Clinical Trial19.3.2018 12:00 | Pressmeddelande
The BETonMACE trial has now surpassed 2,400 enrolled patients and topline data is expected around the end of 2018 CALGARY, Alberta, March 19, 2018 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that it has successfully surpassed the planned enrollment target of over 2,400 patients in the ongoing Phase 3 BETonMACE trial. The trial's first patient was enrolled on November 11th, 2015. The goal of the trial is to confirm the effect of Resverlogix' lead drug, apabetalone, in Cardiovascular Disease (CVD) patients with type 2 Diabetes Mellitus (DM) and low high-density lipoproteins (HDL). The primary endpoint of the BETonMACE trial is designed to establish a relative risk reduction (RRR) of Major Adverse Cardiac Events (MACE), narrowly defined as a single composite endpoint of cardiovascular death, non-fatal myocardial infarction (MI) and stroke. Secondary pre-specified endpoints in the trial will also examine renal function and MACE in patien
SolarWinds Places Highest on the Ability to Execute Axis in 2018 Gartner Magic Quadrant for Network Performance Monitoring and Diagnostics19.3.2018 11:30 | Pressmeddelande
AUSTIN, Texas, March 19, 2018 (GLOBE NEWSWIRE) -- SolarWinds, a leading provider of powerful and affordable IT management software, placed highest on the ability to execute axis in the 2018 Gartner Magic Quadrant for Network Performance Monitoring and Diagnostics1. This Gartner report evaluated 22 suppliers of Network Performance Monitoring and Diagnostics products. The firm's evaluation criteria for ability to execute included the following: product or service, overall viability, sales execution and pricing, market responsiveness and record, marketing execution, customer experience, and operations. Of all the vendors evaluated in the report, SolarWinds placed highest on the ability to execute axis. "For three years in a row, Gartner has positioned us as highest on the ability to execute axis in the Magic Quadrant for Network Performance Monitoring and Diagnostics. In our view, this result confirms our commitment to helping our customers manage their network operations with a powerful
Record High Number of Toll Transactions Cleared in Ireland in 201719.3.2018 10:51 | Pressmeddelande
ISSY LES MOULINEAUX, France, March 19, 2018 (GLOBE NEWSWIRE) -- The number of transactions processed through emovis's toll interoperability cloud-based hub in Ireland has reached a record high with over 50 million transactions cleared in 2017. Thanks to its toll interoperability solution, emovis is contributing to the improved mobility of millions of Irish drivers, by allowing them to travel seamlessly with just one toll tag across the whole country. As of January 2018, over 650,000 toll transponders are in use. With this new success, emovis demonstrates its leadership in designing and operating innovative mobility solutions that offer the best levels of service for road users in Ireland and throughout the world. About eToll.ie emovis was awarded the contract for managing Ireland's toll interoperability hub by the National Roads Authority (now Transport Infrastructure Ireland) in June 2013 following a competitive tender. As part of this contract, emovis designed, developed and is curre
Karolinska Development's portfolio company Forendo Pharma granted a €3 million loan19.3.2018 09:30 | Pressmeddelande
STOCKHOLM, 19 March 2018. Karolinska Development's portfolio company Forendo Pharma announces a €3 million loan grant decision by Business Finland. The purpose of the loan is to support the development of a novel drug for endometriosis treatment. Currently available treatments for endometriosis have limitations in efficacy or cause harmful side effects, due to estrogen depletion. Research findings discovered in Finland have opened new opportunities for targeting endometriotic lesions by inhibiting HSD17B1 enzyme. Forendo Pharma's lead program, the HSD17B1 inhibitor FOR-6219, is about to enter the clinical development phase. The new funding from Business Finland will be used to strengthen Forendo's women's health portfolio with a DUAL HSD (hydroxysteroid dehydrogenase) Inhibitor program, targeting gynaecological conditions, including endometriosis. The DUAL HSD Inhibitor program was initiated in 2016 and Forendo is planning to select the product candidate for further development in 2019
I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.Besök vårt pressrum